- Home
- VCEL vs SANA Comparison
VCEL vs SANA Comparison
Compare VCEL & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VCEL | SANA |
|---|---|---|
| Founded | 1989 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | VCEL | SANA |
|---|---|---|
| Price | $32.94 | $3.11 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $57.75 | $7.80 |
| AVG Volume (30 Days) | 577.3K | ★ 3.7M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.00 | 17.24 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $276,259,000.00 | N/A |
| Revenue This Year | $19.40 | N/A |
| Revenue Next Year | $18.24 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 16.45 | N/A |
| 52 Week Low | $28.95 | $1.98 |
| 52 Week High | $45.97 | $6.55 |
Technical Indicators
Market Signals| Indicator | VCEL | SANA |
|---|---|---|
| Relative Strength Index (RSI) | 43.49 | 40.26 |
| Support Level | $30.41 | $2.88 |
| Resistance Level | $34.77 | $3.43 |
| Average True Range (ATR) | 2.05 | 0.20 |
| MACD | -0.35 | -0.04 |
| Stochastic Oscillator | 12.24 | 17.61 |
Price Performance
Historical ComparisonAbout VCEL Vericel Corporation
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.